SE9402472L - Modifierade ytor - Google Patents

Modifierade ytor

Info

Publication number
SE9402472L
SE9402472L SE9402472A SE9402472A SE9402472L SE 9402472 L SE9402472 L SE 9402472L SE 9402472 A SE9402472 A SE 9402472A SE 9402472 A SE9402472 A SE 9402472A SE 9402472 L SE9402472 L SE 9402472L
Authority
SE
Sweden
Prior art keywords
glutathione
novel
product
modified surfaces
chemisorption
Prior art date
Application number
SE9402472A
Other languages
Unknown language ( )
English (en)
Other versions
SE9402472D0 (sv
Inventor
Ingemar Lundstroem
Pentti Tengvall
Magnus Lestelius
Haakan Nygren
Original Assignee
Forskarpatent I Linkoeping Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskarpatent I Linkoeping Ab filed Critical Forskarpatent I Linkoeping Ab
Priority to SE9402472A priority Critical patent/SE9402472L/sv
Publication of SE9402472D0 publication Critical patent/SE9402472D0/sv
Priority to PCT/SE1995/000825 priority patent/WO1996002838A1/en
Priority to EP95926070A priority patent/EP0719413A1/en
Priority to AU29950/95A priority patent/AU2995095A/en
Publication of SE9402472L publication Critical patent/SE9402472L/sv

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553Metal or metal coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0076Chemical modification of the substrate
    • A61L33/0082Chemical modification of the substrate by reacting with an organic compound other than heparin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE9402472A 1994-07-13 1994-07-13 Modifierade ytor SE9402472L (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9402472A SE9402472L (sv) 1994-07-13 1994-07-13 Modifierade ytor
PCT/SE1995/000825 WO1996002838A1 (en) 1994-07-13 1995-07-04 Glutathione modified surfaces
EP95926070A EP0719413A1 (en) 1994-07-13 1995-07-04 Glutathione modified surfaces
AU29950/95A AU2995095A (en) 1994-07-13 1995-07-04 Glutathione modified surfaces

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402472A SE9402472L (sv) 1994-07-13 1994-07-13 Modifierade ytor

Publications (2)

Publication Number Publication Date
SE9402472D0 SE9402472D0 (sv) 1994-07-13
SE9402472L true SE9402472L (sv) 1996-01-14

Family

ID=20394721

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402472A SE9402472L (sv) 1994-07-13 1994-07-13 Modifierade ytor

Country Status (4)

Country Link
EP (1) EP0719413A1 (sv)
AU (1) AU2995095A (sv)
SE (1) SE9402472L (sv)
WO (1) WO1996002838A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4643004B2 (ja) 1998-01-06 2011-03-02 シーラス コーポレイション 生体材料中の病原体不活性化剤をクエンチするための方法
JP3811008B2 (ja) 1998-08-24 2006-08-16 黒川 清 カルボニルストレス状態改善剤、および腹膜透析液
PL1838355T3 (pl) 2004-10-29 2014-01-31 Cerus Corp Ulepszone sposoby wygaszania dla procesu inaktywacji czerwonych krwinek
EA023596B1 (ru) 2008-04-09 2016-06-30 Сирус Корпорейшн Способы обработки композиции эритроцитов для инактивации патогена

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59106527D1 (de) * 1990-11-14 1995-10-26 Hoffmann La Roche Immunsensorischer Wandler und Verfahren zu seiner Herstellung.
CA2118496C (en) * 1992-04-24 2005-01-11 Roger Randall Charles New Method of reducing microorganism adhesion

Also Published As

Publication number Publication date
AU2995095A (en) 1996-02-16
WO1996002838A1 (en) 1996-02-01
SE9402472D0 (sv) 1994-07-13
EP0719413A1 (en) 1996-07-03

Similar Documents

Publication Publication Date Title
ES2058725T3 (es) Aplicacion transdermica de 2-amino-6-n-propilamino-4,5,6,7-tetrahidrobenzotiazol.
DK1492579T3 (da) Medicinske proteseindretninger med forbedret bioforligelighed
IL113776A0 (en) Dna seqeunces coding for enzymes capable of facilitating the synthesis of linear alpha-1,4 glucans in plants fungi and microorganisms
MX206851B (es) Aril o heteroarilamidas sustituidas que tienen actividad biologica similar a los retinoides.
DE3874119D1 (de) Verfahren zur enzymatischen herstellung von oligodextranen, verwendbar bei der produktion von ersatzmitteln fuer zucker, und diese oligodextrane.
DE60133323D1 (de) Cardioprotektive Phosphonate
ATE458057T1 (de) Varianten der faktor-vii- oder -viia-gla-domäne
EP1438944A3 (en) Absorbent article with an odor control coating
AU2002365646A1 (en) Novel proteins with il-6 inhibiting activity
EP1344827A3 (en) Antifreeze proteins from basidiomycetes
DE60314730D1 (de) Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen
ATA137799A (de) Faktor x-analogon mit verbesserter aktivierbarkeit
AU2001260077A1 (en) Microfiltration using activated carbon
SE9402472L (sv) Modifierade ytor
WO2004085451A3 (en) Office products containing antimicrobial agent
PT1080104E (pt) Certos tiois heteroarilo substituidos inibidores da enzima conversora da endotelina
DE60210970D1 (de) Mutante formen von etxb und ctxb und ihre verwendung als träger
DK0637327T3 (da) Polyetheramidoaminhydrogeler som hepariniserbare materialer
PT1023303E (pt) Promotores de adesao da borracha
MXPA05013328A (es) Preparaciones que contienen por lo menos un hidroformiato.
DE50109809D1 (de) Verfahren zur Herstellung von D- oder L-Menthol
AU7919698A (en) Formic acid solution with reduced corrosive effect
CA2251241A1 (en) Apoptosis inhibitor
DE59805677D1 (de) Froststabilisierung von wässrigen überzugsmitteln durch frostschutzproteine
NO20035853L (no) Biomedisinsk titanimplantat

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9402472-6

Format of ref document f/p: F